StockData
BridgeBio Pharma, Inc. logo

BridgeBio Pharma, Inc. (BBIO) stock

BBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 3/30
$76.80−0.56 (-0.72%)

Close on Nov 17, 2026Market cap $14.96BP/E –Yield –

BridgeBio Pharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

BridgeBio Pharma's price to sales ratio was 21.8× on Nov 11, 2026, against 39.2× a year earlier. Over the last 5 years it ranged from 12.8× to 482.2×, with a median of 27.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202621.8×−19.9
2025Dec 31, 202541.6×+17.8
2024Dec 31, 202423.8×−48.4
2023Jul 31, 202372.2×+59.4
2022Dec 30, 202212.8×−30.2
2021Dec 31, 202143.1×−171.8
2020Dec 31, 2020214.8×–

More BridgeBio Pharma figures

See a number that looks wrong?